Basic Information
Renasym, a drug-induced liver injury simulation platform developed by DILIsym Services, builds PBPK models for specific drugs based on the GastroPlus software. In the research and development of new drugs or generic drugs, pharmaceutical companies can use this simulation platform to quickly screen and test liver damage caused by different drugs, reducing the cost of drug development.
DILIsym Services
Durham,England,United Kingdom
unclear
January 01, 2015
--

